Flywheel, Imbio offer COVID-19 data research tools

By staff writers

March 27, 2020 -- Research informatics company Flywheel and data analysis software provider Imbio have partnered to accelerate researchers' understanding of COVID-19 and potential treatments.

Flywheel, Imbio, and their parent company, Invenshure, have decided to combine technologies to offer researchers powerful tools to aggregate and analyze COVID-19 data.

Beginning March 30, Flywheel's platform, including Imbio's lung analysis tools, will be available for free to COVID-19 academic and clinical researchers. More details will be announced soon.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking